NCT04514484 2026-03-18Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVNational Cancer Institute (NCI)Phase 1 Active not recruiting8 enrolled
NCT00020579 2012-03-15MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaNational Institutes of Health Clinical Center (CC)Phase 1 Completed75 enrolled